featured
Risk of HBV Reactivation During Therapies for HCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of HBV reactivation during therapies for HCC: A systematic review
Hepatology 2022 May 01;75(5)1257-1274, M Papatheodoridi, M Tampaki, AS Lok, GV PapatheodoridisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.